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Abstract The objective of this research was to develop,
optimize, and validate a modern, rapid method of preparation
of human hair samples, using microwave irradiation, for
analysis of eight tricyclic antidepressants (TCADs): nordoxepin,
nortriptyline, imipramine, amitriptyline, doxepin, desipramine,
clomipramine, and norclomipramine. It was based on simulta-
neous alkaline hair microwave-assisted hydrolysis and
microwave-assisted extraction (MAH–MAE). Extracts were
analyzed by high-performance liquid chromatography with
diode-array detection (HPLC–DAD). A mixture of n-hexane
and isoamyl alcohol (99:1, v/v) was used as extraction solvent
and the process was performed at 60°C. Application of
1.0 mol L−1 NaOH and microwave irradiation for 40 min
were found to be optimum for hair samples. Limits of detection
ranged from 0.3 to 1.2 μg g−1 and LOQ from 0.9 to 4.0 μg g−1
for the different drugs. This enabled us to quantify them in
hair samples within average therapeutic concentration ranges.
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Abbreviations
6AM 6-Monoacetylmorphine
Ami Amitriptyline
BZE Benzoylecgonine
CCE Cocaethylene
Clo Clomipramine
DCM Dichloromethane
Des Desipramine
Dox Doxepin
GC–MS Gas chromatography with mass
spectrometric detection
HPLC–DAD High-performance liquid chromatography
with diode-array detection
HS–SPME Head space solid-phase microextraction
Imi Imipramine
IS Internal standard
LLE Liquid–liquid extraction
LOD Limit of detection
LOQ Limit of quantification
MAE Microwave-assisted extraction
MAH Microwave-assisted hydrolysis
MeOH Methanol
Norc Norclomipramine
Nord Nordoxepin
Nort Nortriptyline
PFPA Pentafluoropropionic acid
SPE Solid-phase extraction
TCADs Tricyclic antidepressants
Introduction
Remarkable advances in sensitive analytical techniques have
enabled the analysis of substances in such unconventional
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biological specimens as hair [1]. In recent years, hair analysis
has become prevalent in forensic and clinical toxicology [2–
4]. Various organic substances have been found and
determined in hair, e.g. drugs of abuse, psychotropic drugs,
doping agents, steroids, alcohol, and their metabolites [5–7].
Moreover, correlations have been found between concen-
trations of drugs in plasma and hair. Kintz et al. showed that
when the concentration of clozapine in plasma was elevated,
the corresponding hair content of this drug also increased
[8]. In another study, Pragst et al. indicated that drugs are
about ten times more concentrated in hair than in plasma [9].
The results of studies of Beumer et al. also showed a
correlation between plasma and the hair concentration of
such psychotropic drugs as carbamazepine, amitriptyline,
and chlorpromazine [10].
Toxicologically, hair belongs to the group of so-called
alternative materials (similarly to sweat, oral fluid, nails,
vitreous humor, meconium, and tears). Hair analysis provides
a wide window of detection of xenobiotics and their
metabolites, because many compounds become incorporated
into the structure of hair. Thus, it provides information on drug
intake for a long time after the drug has been excreted from the
human body [9, 11]. Moreover, it has been shown elsewhere
that hair analysis gives great possibilities of distinguishing
between acute, chronic, and one-time substance use [12, 13].
The first time a hair sample was used for toxicological
analysis was in the 18th century for determination of arsenic in a
postmortem hair sample [14]. However, it was not until
Baumgartner et al. carried out research in 1979 on the
application of a radioimmunological method for detection of
opiates in hair that analysis of this kind of biological matrix
began to develop rapidly [3, 15]. The determination of
psychotropic drugs, for example benzodiazepines, neuroleptics,
anesthetics, hypnotics, and sedatives, has recently been
reviewed by Wada et al. [5]. Examples of determination of
frequently prescribed [16] tricyclic antidepressants (TCADs)
have also been published [9, 17–20].
TCADs have been used for treatment of depression since the
middle of the 20th century. The therapeutic mechanism of
tricyclic antidepressants is still not known, but it is probably
related to reduced norepinephrine and serotonin reuptake.
However, because of their narrow therapeutic range, these drugs
are often overdosed and used for self-poisoning [16]. Moreover,
they are more toxic than selective serotonin reuptake inhibitors,
but despite this drawback they are still prescribed because of
their high and proved efficacy in the treatment of patients.
The mechanism of drug incorporation into hair has still
not been clarified. Chemical and physical properties of
drugs (for example lipophilicity, pKa) and hair structure (the
isoelectric pH of hair is approximately 6) have a strong
effect on the mechanism of incorporation [3, 4, 13]. The
affinity of particular substances for hair probably also
depends on the melanin content, which is acidic (pH 3–5)
[9]. This may be a reason why basic drugs, for example
TCADs, are more readily absorbed into hair than acidic
substances [3]. Moreover, deposition of hydrophilic metabolites
into hair is less efficient than deposition of the parent drug [18].
The opposite situation is observed for blood, in which the
concentrations of the parent drugs are lower than those of their
metabolites. Reference TCAD concentrations in hair cover a
wide range from <0.1 to 183.3 μg g−1 [3, 9, 17, 19, 20]. It
should be emphasized that there is no specified concentration
range correlated with dosage or treatment, and the reported
concentration varies between authors.
Hair analysis provides much valuable information, but
pretreatment of hair samples is time-consuming and laborious.
The chemical structure of a drug and its sensitivity to agents
used for sample preparation should be taken into consideration.
First, hair should be washed (with, e.g., sodium dodecylsulfate
solution) and dried at room or elevated temperature. The sample
must then be digested in alkaline or acidic solution [18].
Enzymatic hydrolysis may also be applied [21], and a simple
methanolic bath [18]. In the next step, the analytes are isolated
with an extraction technique, for example liquid–liquid
extraction [22], solid-phase extraction [23], or solid-phase
microextraction [24]. These steps may take up to 12 h or more,
which is why it is so important to develop a fast and simple
hair-sample-preparation technique. The most commonly used
sample-preparation techniques, with additional information
about subsequent extraction and method of analysis, are
presented in Table 1.
In recent years, much attention has been devoted to
application of microwave energy in sample preparation.
Microwave-assisted extraction (MAE) is a process which
involves using microwave energy to heat the extraction
solvent–sample system and to transfer compounds of interest
from the matrix into the extraction solvent. Supporting the
liquid–liquid extraction with microwaves can make the MAE
method even more efficient than conventional extraction
techniques [27]. The main advantages of using microwave
irradiation at the preparation stage are reduction of extraction
time, reduced consumption of solvents, and increased recovery
of an isolated analyte. Moreover, it is easy to perform.
Microwave irradiation was used for the first time in the
laboratory by Abu-Samara et al. to prepare biological samples
for trace analysis of metals [28]. Since then, microwave-
assisted extraction has also been successfully applied to
preparation of samples for analysis of organic compounds in
difficult matrices, for example blood, serum, plasma, urine,
saliva, human hair, tablets, and suppositories [29–37].
The first paper about the application of microwave-assisted
extraction in hair analysis was published by Álvarez et al in
2009 [37]. They described a simple and rapid method for
isolation of ethyl glucuronide—a promising general marker
of alcohol consumption—from hair by MAE. Another paper
devoted to application of MAE in hair analysis was
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published in 2009. Fernandez et al. [34] successfully used
microwave irradiation for simultaneous extraction of six
illegal drugs of abuse (cocaine, BZE, CCE, morphine,
6 AM, and codeine) from human hair samples. The
recoveries of isolated drugs were close to 100%. The
optimum MAE method was compared with the MAE
technique preceded by enzymatic or acid digestion. When
the procedures as a whole were compared, it was found that
similar recoveries were achieved—ranging from 86 to 100%.
However, to the best of our knowledge, there has been no
publication describing the application of microwave radiation
to isolation of tricyclic antidepressant drugs from human hair.
As TCADs are still commonly prescribed drugs, there is a
persistent need to develop effective methods for isolation of
these compounds from a variety of matrices. Within the
framework of this research, simultaneous microwave-assisted
hydrolysis and extraction (MAH–MAE) of tricyclic antide-
pressants from human hair has been developed. Sample
preparation was followed by analysis by high-performance
liquid chromatography with diode-array detection. The method
was optimized and validated for analysis of eight TCADs and
their metabolites (Ami, Des, Dox, Imi, Nord, Nort, Norc, and
Clo) in human hair for forensic and clinical purposes.
Experimental
Reagents and materials
HPLC-gradient-grade acetonitrile and methanol were supplied
byMerck (Darmstadt, Germany). Orthophosphoric acid (85%),
30% aqueous NaOH solution, n-hexane, acetone, and isoamyl
Table 1 Conventional sample preparation and extraction methods for TCADs from hair
Drugs Pretreatment Extraction procedure Method of analysis Ref.
Amitriptyline, doxepin Alkaline digestion LLE from pH 9.5–10 to ether;
dry residue dissolved in MeOH
GC–MS [18]
10–20 mg hair with 0.1 mol L−1
NaOH at 80 °C for 30 min
Acidic hydrolysis
10–20 mg hair incubated in 1 mL
0.1 mol L−1 HCl at 45 °C for 18 h
Methanol extraction
10–20 mg of hair with 2 mL
methanol in an ultrasonic
bath for 1 h, then incubation
at room temperature overnight
Amitriptyline (nortriptyline),
clomipramine (norclomipramine),
doxepin (nordoxepin), imipramine
(desipramine)
Alkaline digestion LLE (Extrelut column)
ethyl acetate–ether (1:1, v/v),
evaporation to dry residues,
derivatization with PFPA,
dry residue dissolved in ethyl
acetate
GC–MS [9]
7-30 mg hair with 0.1 mol L−1
NaOH at 80 °C for 30 min
Methanol extraction
7–30 mg hair with methanol,
in ultrasonic bath for 2 h,
then incubation for 18 h
Amitriptyline, doxepin,
imipramine, triimipramine
Alkaline digestion HS-SPME to polyacrylate fiber
(85 μm); fiber exposure
for 20 min
GC–MS [24]
10 mg hair with a mixture of 1 mL 0.4%
NaOH and 0.5 g Na2SO4 for 30 min (90 °C)
Amitriptyline (nortriptyline),
doxepin (nordoxepin), imipramine
(desipramine) trimipramine
Alkaline digestion LLE from alkaline medium to
hexane–butanol (95:1, v/v);
back-extraction to 0.2%
orthophosphoric acid
HPLC [25]
5–25 mg hair with 1 mL 1 mol L−1
NaOH, incubation for 30 min at 70 °C
Acidic hydrolysis
5–25 mg hair with 1 mL 0.1 mol L−1
HCl for 18 h at 55 °C
Methanol extraction
5–25 mg hair with 1 mL methanol
for 18 h at 70 °C
Enzymatic hydrolysis
5–25 mg hair with subtilisin for
18 h at 55 °C
Amitriptyline, clomipramine Acid hydrolysis SPE (C18): elution solvent:
methanol with 0.5% glacial
acetic acid; dry residue
dissolved in MeOH
HPLC [26]
75 mg ground hair with 1 mL
0.1 mol L−1 HCl for 12 h at 56 °C
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alcohol, all of analytical grade, were purchased from POCh
(Gliwice, Poland). Drug standards, sodium dodecylsulfonate,
and diethylamine were purchased from Sigma–Aldrich (St
Louis, MO, USA). Deionized water (<1.0 μS cm−1) was used
throughout.
Standards
Drug stock solutions (10 mg mL−1) were prepared in
methanol and stored in a refrigerator (+4°C). Spiking
solutions were prepared daily by appropriately diluting stock
solutions with deionized water. Standard drug solutions were
prepared by diluting stock solutions with 0.05% H3PO4 to a
concentration of 3.6 μg mL−1 (corresponding to 4 μg g−1 in
a 45-mg hair sample). Each drug: Ami, Des, Dox, Imi, Nord,
Nort, Norc and Clo was tested in the concentration range
2.5–20.0 μg g−1 hair. Clomipramine (40 μg g−1) was used as
the internal standard for Ami, Des, Dox, Imi, Nord and Nort,
whereas imipramine (40 μg g−1) was used as the IS in
analysis of patient’s hair for Norc and Clo.
Apparatus and conditions
Hair samples (ca. 70 mg) were ground with a ball-grinder
(Retsch, Germany) for 10 min. A MARS X microwave-
assisted sample preparation system (CEM, Matthews, USA),
equipped with 14 pressurized 100-mL GreenChem PTFE
vessels was used for isolation of the analytes from the hair
matrix. An internal system enabled power and temperature to
be regulated up to 1200 W and 240°C, respectively.
A Merck–Hitachi LaChrom (Germany-Japan) high-
performance liquid chromatograph consisting of an L-7100
pump, an L-7200 autosampler, and an L-7455 programmable
diode-array detector coupled to a PC with D-7000 HSM
software was used. The mobile phase was prepared by mixing
acetonitrile and phosphoric buffer (40:60, v/v). Phosphoric
buffer (pH 2.36) was prepared by adding 1.4 mL 85%
phosphoric acid and 1 mL diethylamine to a volumetric flask
(1 L) and diluting to volume with deionized water. Before
analysis the mobile phase was filtered with a modified
cellulose filter (0.45 μm) (Sartorius, Germany) and degassed
in an ultrasonic bath. For each analysis, 10 μL sample solution
was injected by an autosampler and separation was carried out
on a Spheri-5 C18 column, 100 mm×4.6 mm I.D., particle size
5 μm (Perkin–Elmer, USA). The flow rate was 1 mL min−1.
The column was thermostated at 50 °C. Chromatograms were
acquired at 254 nm and calibration curves were calculated
using peak-height ratios (drug/IS).
Hair sample pretreatment
Drug-free control hair samples were taken from volunteers
with dark blond hair and stored in sealed polyethylene
bags, at room temperature in a dry and dark place until
analysis. Hair samples, cut from the vertex posterior, were
collected from a patient who had been chronically treated
with psychotropic drugs. Before analysis all hair samples
were rinsed, using, in sequence, 0.1% sodium dodecylsulfate,
water, acetone, and water to eliminate any external contamina-
tion. After drying at room temperature, the hair was cut into
small pieces (ca. 2mm long), ground, and 45mg powdered hair
was weighed in a PTFE extraction vessel.
Hair sample preparation
Because no hair reference material was available for determi-
nation of tricyclic antidepressants, spiked samples were used
throughout. The concentration of each drug was 4 μg g−1. To
each sample (45 mg), 4 mL 1.0 mol L−1 NaOH was added
and the contents were then gently mixed. Extraction solvent
(n-hexane–isoamyl alcohol, 99:1, v/v, 5 mL) was then added.
Then the vessels were closed and placed in the microwave
system, where, for 40 min at 60°C, alkaline microwave-
assisted hydrolysis (MAH) and microwave-assisted extrac-
tion (MAE) were performed simultaneously. The tempera-
ture and the composition of the extracting solvent were taken
from a previous paper [27]. The other conditions were
established during the optimization process described below.
After the microwave-assisted procedure, the vessels were
cooled to room temperature. Then, the contents of each
vessel was transferred to a glass tube, using 1 mL organic
solvent to rinse the vessel. Next, the glass tubes were closed
and centrifuged for 10 min (4500 rpm). In the next step,
5 mL of the organic layer was separated and evaporated to
dryness under a stream of nitrogen at 40 °C. The residue was
then dissolved in 250 μL extraction solvent and back-
extracted into 50 μL 0.05% H3PO4. The centrifuged water
layer was then taken for chromatographic analysis.
Results and discussion
Optimization of MAH–MAE conditions
To develop an effective and quick method of hair sample
preparation for analysis of tricyclic antidepressant drugs,
microwave irradiation was used in the preparation step. The
objective of this procedure was to combine alkaline hair
hydrolysis and solvent extraction in a single step. This
combination provides a way of limiting operations on a
sample and in this way the risk of sample and/or analyte
loss is reduced. Moreover, because of the application of
microwave assistance this procedure is less time-consuming
and extraction efficiency is high.
In the preliminarily research, a combination of
microwave-assisted hydrolysis (MAH) and microwave-
3236 R. Wietecha-Posłuszny et al.
assisted extraction (MAE) was investigated. Tricyclic
antidepressants are mainly basic (pKa ca. 9.5), so an
alkaline solution was used to digest the hair sample. The
high pH of the product obtained by hydrolysis offers the
possibility of combining hydrolysis and extraction during
preparation of hair samples.
Microwave-assisted hydrolysis and extraction procedures
were carried out in two ways (Table 2)—simultaneously and
separately (i.e. one after the other). The extraction conditions,
for example extracting solvent, duration, and temperature of
the process were well defined in our previous work [27]. A
temperature of 60 °C, found optimum for microwave-assisted
extraction of tricyclic drugs [27], is also suitable for alkaline
hydrolysis of hair. Application of a higher temperature may
accelerate hair digestion, but also results in a risk of losing
analytes or exceeding a safe organic vapor level in the
microwave oven chamber. The authors found that application
of 80 °C during simultaneous processes always led to loss of
samples. Standard alkaline hydrolysis of hair samples
followed by extraction usually takes more than an hour, but
application of microwave heating should accelerate the
processes, thus the evaluation was performed after 15 and
30 min.
To find the best combination of MAH and MAE, the
results obtained were compared in terms of efficiency,
measured by peak height. The results obtained are
presented in Fig. 1. Use of the process for 15 min was
insufficient to enable successful isolation of analytes from
hair structure, both for simultaneous and separate hydrolysis
and extraction. Results obtained after 30 min indicated the
superiority of MAH–MAE processes performed at the same
time.
In the next step, two factors affecting microwave-assisted
hydrolysis and extraction were taken into consideration: the
Table 2 Hydrolysis and extraction procedures in the preliminary research
Simultaneous hydrolysis and extraction Separate hydrolysis and extraction
Procedure MAH–MAE: Add 4 mL 0.6 mol L−1
NaOH and 5 mL extraction solvent
to 45 mg hair then start microwave oven
MAH: Add 1 mL 0.6 mol L−1 NaOH to 45 mg
hair and run microwave oven (15 or 30 min);
then cool to 40°C
MAE: Add 3 mL 0.6 mol L−1 NaOH and 5 mL
extraction solvent and start microwave oven
Process temperaturea 60°C
Ramping time 2 min 2 min
Time of hydrolysis 15 min 15 min
30 min 30 min
Time of extraction –b 1 mina
Extraction solventa Mixture of n-hexane and isoamyl alcohol (99:1, v/v)
a Conditions adopted from previous experiments [27]
b Extraction took place together with hydrolysis
Fig. 1 Comparison of simultaneous and separate MAH–MAE
procedures. Drug concentration 4 μg g−1
Fig. 2 Comparison of the effect of hydrolysis time and NaOH
concentration on isolation of the studied drugs by the simultaneous
MAH–MAE method
Microwave-assisted hydrolysis and extraction of tricyclic antidepressants from human hair 3237
duration of microwave exposure and the concentration of
sodium hydroxide. The combined MAH–MAE method was
carried out for 20, 30, and 40 min of effective microwave
radiation time (ramping and cooling time excluded) using 0.6
and 1.0 mol L−1 NaOH. Each experiment was repeated four
times (n=4). The drug isolation efficiency was used as an
evaluation factor: the ratio of the mean height of peaks
recorded for all analytes when a sample was determined to
the analogous value obtained for the standard drug solution
(with analytes at the same concentrations). When the process
was performed with use of 0.6 mol L−1 NaOH for 20 min, it
was found to be evidently inefficient. Application of
1.0 mol L−1 NaOH for 20 and 40 min resulted in
significantly higher extraction efficiency (Fig. 2), but the
repeatability of the 20-min process (13.3%) was poorer than
that obtained after 40 min (5.8%).
Finally, the optimum conditions for the MAH–MAE
process were selected as 40 min with 1.0 mol L−1 NaOH.
Under these conditions, extraction efficiency for each drug
ranging from 101.1% (Dox) to 108.3% (Ami) was
achieved.
Validation step
Validation of the MAH–MAE/HPLC–DAD method for
determination of eight tricyclic antidepressants and their
metabolites in human hair was performed. For determina-
tion of Ami, Des, Dox, Imi, Nord, and Nort, clomipramine
was used as an internal standard whereas for determination
of Clo and Norc, imipramine was used. The results are
presented in Table 3.
The limits of detection (LOD) and quantification (LOQ)
were calculated as three times and ten times the SD-to-
slope coefficient ratio, respectively. The LOD ranged from
0.3 μg g−1 for imipramine to 1.1 μg g−1 for desipramine
and nortriptyline, whereas the LOQ varied from 0.9 μg g−1
for imipramine to 4.0 μg g−1 for norclomipramine. The
linear range was expressed as the range from the LOQ to
Table 3 Results from validation of the MAH–MAE/HPLC method for analysis of eight TCADs
Nord Dox Des Nort Imi Ami Cloa Norca
Internal standard Clo Clo Clo Clo Clo Clo Imi Imi
Linearity (μg g−1) LOQ–20.0 (n=4)
Slope 0.097 0.125 0.067 0.0484 0.093 0.045 0.00466 0.0049
Intercept −0.074 −0.041 −0.029 −0.0061 −0.046 −0.023 −0.00075 0.0080
Correlation coefficient. R2 0.9984 0.9977 0.9977 0.9999 0.9962 0.9940 0.9992 0.9976
LOD (μg g−1) 0.9 0.5 1.1 1.1 0.3 0.7 0.7 1.2
LOQ (μg g−1) 3.1 1.7 3.7 3.7 0.9 2.3 2.3 4.0
Precision 4 μg g−1, RSD (%) Intraday 10.2 4.9 10.4 9.5 2.5 5.9 4.9 5.7
Interday 11.8 9.2 12.1 10.7 5.9 7.0 6.1 10.2
Precision 10 μg g−1, RSD (%) Intraday 4.3 3.4 2.1 5.0 3.1 2.6 2.2 5.7
Interday 9.8 4.9 2.6 9.4 3.7 2.8 4.1 7.0
Precision 18 μg g−1, RSD (%) Intraday 6.0 6.8 2.2 2.0 6.0 3.2 3.3 4.8
Interday 6.8 7.2 4.5 4.8 6.9 4.3 3.8 5.2
Table 4 Recovery of TCADs from human hair by use of simultaneous MAH–MAE (n=4)
Drug Low concentration (μg g−1) Medium concentration (μg g−1) High concentration (μg g−1)
Expected Found Recovery (%) RSD (%) Expected Found Recovery (%) RSD (%) Expected Found Recovery (%) RSD (%)
Nord 4.0 3.6 88.8 10.7 10.0 9.1 91.1 6.7 18.0 18.0 100.0 5.0
Dox 4.0 99.8 4.0 10.4 103.1 5.6 17.5 97.2 6.8
Des 3.6 89.8 11.1 9.9 96.8 9.2 17.8 98.9 1.7
Nort 3.7 91.3 11.9 9.4 91.6 5.1 17.8 98.9 1.9
Imi 4.1 103.5 2.7 10.4 99.9 3.3 17.4 96.7 5.9
Ami 4.4 110.3 3.8 10.7 101.4 2.9 17.4 96.7 3.5
Norc 4.1 101.5 9.9 10.3 97.1 5.4 17.7 98.3 3.1
Clo 4.4 110.8 4.9 11.3 105.5 2.1 17.9 99.4 2.8
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the maximum measured concentration (20 μg g−1) for
which R2>0.994. The values obtained enabled analysis of
TCADs present in hair at average therapeutic levels.
The precision of the method, expressed as the
repeatability of the measured concentration was estimated
by analysis of four different hair samples spiked with
analytes at concentrations of 4.0, 10, and 18.0 μg g−1.
The measurements were repeated on another day. In this
way, intraday and interday precision was calculated. The
results obtained revealed (Table 3) that for low and
medium concentrations, application of the simultaneous
MAH–MAE method with HPLC–DAD determination was
more precise for less polar parent TCADs (amitriptyline,
imipramine, doxepin, and clomipramine) than for metabolites.
The recovery (R) was calculated as the ratio of the found
concentration (cf) to the expected concentration (ce), after
spiking a sample:
R ¼ cf
ce
 100%
The results obtained from analysis of four samples are
presented in Table 4. The recoveries, calculated for all the
analytes, ranged from 88.8 to 110.8% at low concentration
(4 μg g−1), from 91.1 to 105.5% at medium concentration
(10 μg g−1), and from 96.7 to 100.0% at high concentration
(18 μg g−1).
Case study
A 32-year-old woman (with ca. 20 cm long, blond, not
bleached or dyed hair) suffering from depression, was
treated with 112.5 mg Anafranil (clomipramine hydrochloride,
Novartis, Switzerland) daily for one year and then at 25 mg per
day for the following 6 months (18 months before collection of
hair samples). Because the authors wanted to check if
clomipramine or its nor-metabolite were present in her
hair, a strand ca. 20 cm long from the vertex posterior of
the head and 4 cm long endings were taken for analysis.
Studies were carried out for four samples (endings) and a
blank hair sample, 45 mg each. All samples were spiked
with internal standard (imipramine) and treated according
to the optimized MAH–MAE method. The extracts obtained
were then analyzed by HPLC–DAD. Results from analysis
revealed only a peak corresponding to norclomipramine
(Fig. 3). Peak identification was confirmed by comparison
of UV spectra; the concentration of norclomipramine in hair
was 5.3±0.3 μg g−1.
The absence of clomipramine could have been caused by the
different polarity of the parent drug and its metabolite and by
the properties of the hair. The more polar desmethyl metabolite
norclomipramine is more slowly eliminated from hair than the
parent drug. Moreover, for tricyclic antidepressants, the mean
drug concentration slowly decreases with increasing distance
from the hair root (i.e., increasing age of the hair). So that after
more than one year in the hair, (i.e. more than 12–15 cm from
the root), about 4% of the drugs remain present [13]. The hair
samples of the patient were taken after she had finished
18 months of treatment with Anafranil. It is possible that only
a small amount (less than the LOD) of clomipramine
remained in the patient’s hair.
Conclusion
Within the framework of this study, a modern simultaneous
MAH–MAE method for hair sample preparation, before
analysis of tricyclic antidepressant drugs in human scalp hair
by use of HPLC–DAD, was developed. It combines two
laborious hair-sample-preparation steps: alkaline hydrolysis
and extraction of analytes in a single operation. Because of
this combination, the procedure proposed is evidently less
time-consuming and more effective than the conventional
sample preparation procedure involving alkaline hydrolysis.
According to the literature [18], the efficiency of classic
liquid extraction ranges from 64.6 to 88.1%, whereas the
authors’ method is characterized by efficiency close to
100%. Moreover, the fact that these processes are performed
together, that up to 14 samples can be prepared in a single
microwave oven run, and that samples only have to be
cooled once are great advantages of the proposed procedure.
It should also be emphasized that application of
microwave energy supports both alkaline hydrolysis and
extraction, thus high recovery of tricyclic antidepressant
drugs was achieved.
Analysis of the real hair sample collected from the
patient treated with tricyclic antidepressants confirmed the
reliability of the method.
The results obtained show that the method is reliable and
may be used in clinical laboratories for therapeutic
Fig. 3 Results from analysis of patient’s hair
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monitoring of TCADs and in forensic laboratories for their
analysis at therapeutic and higher levels in human hair.
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